Who is sponsoring NCT03544359?

NCT03544359 is sponsored by Northwestern University.

What drugs are being tested in NCT03544359?

Interventions in NCT03544359: Transcranial electrical stimulation (tES).

What condition does NCT03544359 study?

NCT03544359 studies Tinnitus, Subjective.

Is NCT03544359 still recruiting?

NCT03544359 is currently completed. Last updated 9 February 2023.

Last reviewed 2023-02-09 · How we verify

NCT03544359

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MRI Study of Noninvasive Transcranial Electrical Stimulation in Tinnitus

Completed EARLY_PHASE1 Last updated 9 February 2023

What this trial tests

EARLY_PHASE1 trial testing Transcranial electrical stimulation (tES) in Tinnitus, Subjective in 20 participants. Completed in 13 December 2022.

Timeline

1 August 2018

Primary endpoint
13 December 2022

13 December 2022

Quick facts

Lead sponsor	Northwestern University
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	20
Start date	1 August 2018
Primary completion	13 December 2022
Estimated completion	13 December 2022
Sites	1 location across United States

Drugs / interventions tested

Transcranial electrical stimulation (tES)

Conditions studied

Tinnitus, Subjective — all drugs for Tinnitus, Subjective →

Sponsor

Northwestern University

Who can join

Adults 18 to 65, any sex, with Tinnitus, Subjective. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to understand how a neuromodulation technique, transcranial electrical stimulation (tES), affects brain function in adults with chronic tinnitus measured with functional magnetic resonance imaging (fMRI). We hypothesize that multiple sessions of tES (5 consecutive days) will modulate: 1. Overall activity and local connectivity within brain regions near tES electrodes, and 2. Functional connectivity within brain networks associated with brain regions near tES electrodes. In exploratory analyses, we also measure the extent to which the hypothesized changes listed above a related to changes in tinnitus symptoms after tES.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tinnitus, Subjective

Currently open trials in the same condition.

NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
NCT07071480 — Noninvasive Therapy for Tinnitus · NA · recruiting
NCT07017998 — External Therapy for Tinnitus Management · NA · recruiting
NCT06880367 — Neuromodulatory Effects of Audio-proprio-phonatory Reinforcement Training on Subjective Tinnitus, Demonstrated by High-d · NA · recruiting
NCT06782308 — Tinnitus Patient Preferences Survey · recruiting

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03544359 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 9 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03544359.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing